MX2014008893A - Fenilimidazopirazoles sustituidos y su uso. - Google Patents

Fenilimidazopirazoles sustituidos y su uso.

Info

Publication number
MX2014008893A
MX2014008893A MX2014008893A MX2014008893A MX2014008893A MX 2014008893 A MX2014008893 A MX 2014008893A MX 2014008893 A MX2014008893 A MX 2014008893A MX 2014008893 A MX2014008893 A MX 2014008893A MX 2014008893 A MX2014008893 A MX 2014008893A
Authority
MX
Mexico
Prior art keywords
medicaments
diseases
prevention
phenylimidazopyrazoles
substituted
Prior art date
Application number
MX2014008893A
Other languages
English (en)
Inventor
Michael Härter
Bernd Buchmann
Klemens Lustig
Mario Lobell
Antje Kahnert
Frank Süssmeier
Hannah Jörissen
Joachim Telser
Niels Lindner
Sylvia Grünewald
Mélanie Héroult
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47594775&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2014008893(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of MX2014008893A publication Critical patent/MX2014008893A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invención se refiere a nuevos derivados de 1-fenil-1H-imidazo[1,2-b]pirazol, a procedimientos para su preparación, a su uso para el tratamiento y/o la prevención de enfermedades así como a su uso para la preparación de medicamentos para el tratamiento y/o la prevención de enfermedades, en particular de enfermedades angiogénicas y de enfermedades hiperproliferativas en las que es importante la neovascularización, como por ejemplo, enfermedades cancerosas y tumorales. Tales tratamientos pueden realizarse como monoterapia o también en combinación con otros medicamentos u otras medidas terapéuticas.
MX2014008893A 2012-01-25 2013-01-22 Fenilimidazopirazoles sustituidos y su uso. MX2014008893A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12152515 2012-01-25
PCT/EP2013/051106 WO2013110590A1 (de) 2012-01-25 2013-01-22 Substituierte phenylimidazopyrazole und ihre verwendung

Publications (1)

Publication Number Publication Date
MX2014008893A true MX2014008893A (es) 2014-08-26

Family

ID=47594775

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014008893A MX2014008893A (es) 2012-01-25 2013-01-22 Fenilimidazopirazoles sustituidos y su uso.

Country Status (31)

Country Link
US (2) US20150005288A1 (es)
EP (1) EP2807162B1 (es)
JP (1) JP6101290B2 (es)
KR (1) KR20140117582A (es)
CN (1) CN104411707B (es)
AP (1) AP2014007869A0 (es)
AR (1) AR089788A1 (es)
AU (1) AU2013211707A1 (es)
BR (1) BR112014018450A8 (es)
CA (1) CA2862163A1 (es)
CL (1) CL2014001959A1 (es)
CO (1) CO7101244A2 (es)
CR (1) CR20140362A (es)
CU (1) CU20140096A7 (es)
DO (1) DOP2014000173A (es)
EA (1) EA201491427A1 (es)
EC (1) ECSP14010868A (es)
ES (1) ES2639338T3 (es)
GT (1) GT201400161A (es)
HK (1) HK1203198A1 (es)
IL (1) IL233652A0 (es)
MA (1) MA35877B1 (es)
MX (1) MX2014008893A (es)
PE (1) PE20142421A1 (es)
PH (1) PH12014501687A1 (es)
SG (1) SG11201404118XA (es)
TN (1) TN2014000320A1 (es)
TW (1) TW201343649A (es)
UY (1) UY34590A (es)
WO (1) WO2013110590A1 (es)
ZA (1) ZA201405392B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104411707B (zh) * 2012-01-25 2017-03-01 拜耳药业股份公司 取代的苯基咪唑并吡唑及其用途
EP3027026A4 (en) 2013-07-31 2017-05-03 Windward Pharma, Inc. Aerosol tyrosine kinase inhibitor compounds and uses thereof
WO2016071499A1 (en) 2014-11-06 2016-05-12 Basf Se 3-pyridyl heterobicyclic compound for controlling invertebrate pests
JP6937748B2 (ja) * 2015-10-08 2021-09-22 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ 複素環で置換した二環式アゾール有害生物防除剤
UY38366A (es) * 2018-09-13 2020-04-30 Syngenta Participations Ag Compuestos de azol-amida pesticidamente activos
CN109096195A (zh) * 2018-09-27 2018-12-28 上海雅本化学有限公司 一种艾曲波帕的制备方法
WO2021074108A1 (de) * 2019-10-16 2021-04-22 Bayer Aktiengesellschaft Verfahren zur herstellung von 1,1'-disulfandiylbis(4-fluor-2-methyl-5-nitrobenzol)
MX2022009369A (es) * 2020-01-29 2022-10-27 Foghorn Therapeutics Inc Compuestos y usos de estos.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753730B2 (ja) * 1988-07-26 1995-06-07 三共株式会社 イミダゾピラゾール誘導体
UA80171C2 (en) * 2002-12-19 2007-08-27 Pfizer Prod Inc Pyrrolopyrimidine derivatives
US7419978B2 (en) * 2003-10-22 2008-09-02 Bristol-Myers Squibb Company Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
KR101061599B1 (ko) * 2008-12-05 2011-09-02 한국과학기술연구원 비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물
ES2632220T3 (es) * 2009-06-15 2017-09-11 Rigel Pharmaceuticals, Inc. Inhibidores de moléculas pequeñas de tirosina cinasa del bazo (SYK)
KR101116756B1 (ko) * 2009-10-27 2012-03-13 한국과학기술연구원 단백질 키나아제 저해활성을 갖는 신규의 1,6-치환된 인돌 화합물
CN104411707B (zh) * 2012-01-25 2017-03-01 拜耳药业股份公司 取代的苯基咪唑并吡唑及其用途

Also Published As

Publication number Publication date
AU2013211707A1 (en) 2014-08-07
CN104411707B (zh) 2017-03-01
ES2639338T3 (es) 2017-10-26
EP2807162A1 (de) 2014-12-03
BR112014018450A8 (pt) 2017-07-11
JP6101290B2 (ja) 2017-03-22
CL2014001959A1 (es) 2014-11-07
US20130190290A1 (en) 2013-07-25
MA35877B1 (fr) 2014-12-01
TN2014000320A1 (en) 2015-12-21
AR089788A1 (es) 2014-09-17
ZA201405392B (en) 2015-12-23
BR112014018450A2 (es) 2017-06-20
KR20140117582A (ko) 2014-10-07
TW201343649A (zh) 2013-11-01
PE20142421A1 (es) 2015-01-11
WO2013110590A1 (de) 2013-08-01
CR20140362A (es) 2014-08-21
CA2862163A1 (en) 2013-08-01
CO7101244A2 (es) 2014-10-31
CN104411707A (zh) 2015-03-11
AP2014007869A0 (en) 2014-08-31
UY34590A (es) 2013-09-02
US20150005288A1 (en) 2015-01-01
US9394309B2 (en) 2016-07-19
PH12014501687A1 (en) 2014-10-20
EP2807162B1 (de) 2017-06-07
GT201400161A (es) 2015-03-05
EA201491427A1 (ru) 2015-01-30
HK1203198A1 (en) 2015-10-23
IL233652A0 (en) 2014-08-31
CU20140096A7 (es) 2015-02-26
DOP2014000173A (es) 2014-08-31
ECSP14010868A (es) 2015-12-31
SG11201404118XA (en) 2014-10-30
JP2015504904A (ja) 2015-02-16

Similar Documents

Publication Publication Date Title
TN2014000320A1 (en) Substituted phenylimidazopyrazoles and use thereof
NZ720736A (en) Antibody drug conjugates (adcs) with kinesin spindel protein (ksp)
TN2015000169A1 (en) Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
TN2012000428A1 (en) Bisaryl-bonded aryltriazolones and use thereof
MY181828A (en) Bicyclically substituted uracils and the use therapy
SG10201808102WA (en) Bicyclic heterocycle compounds and their uses in therapy
JO3199B1 (ar) مركبات 5- فلورو-1h- بيرازولوبيريدينات مستبدلة واستخدامها
WO2012143497A3 (de) Neue binder-wirkstoff konjugate (adcs) und ihre verwendung
MX343706B (es) Derivados heterocíclicos novedosos.
PH12016500065A1 (en) Benzyl-1h-pyrazolo[3,4-b]pyridines and use thereof
MX2015004362A (es) Derivados de ketamina.
MX2012012960A (es) Heterociclilbencilpirazoles sustituidos y uso de los mismos.
JOP20200073A1 (ar) مركبات أميد إيميدازوبيريدين تحمل بدائل واستخداماتها
PH12016500608A1 (en) Cyclic thienouracil-carboxamides and use thereof
MX2013002208A (es) Derivados de sulfonilpiperazina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes.
SG11201902588PA (en) N3-Cyclically Substituted Thienouracils And Use Thereof
MX2012012905A (es) Hidroxialquilbencilpirazoles y su uso para tratamiento de enfermedades hiperproliferativas y angiogenicas.
MX2013002261A (es) N-fenetiltriazolonacetamidas sustituidas y su uso.
NZ631362A (en) Arry-520 for use in treating cancer in a patient with low aag
MX2019009733A (es) 3'-deamino-3'-(2''-pirrolin-1''-il)-5-imino-13-desoxiantraciclina s y metodos de preparacion.
UA103784C2 (ru) Гетероциклически замещенные арильные соединения как ингибиторы гиф
TN2013000327A1 (en) Novel heterocyclic derivatives
UA92302C2 (ru) Лекарственное средство для терапии злокачественных опухолей и способ лечения злокачественных опухолей с его использованием